Celiac Disease Monitoring Test

Celiac disease is one of the most under diagnosed diseases in the world, and yet affects almost 3 million Americans.

It is a condition where the absorptive surface of the small intestine is damaged by a substance called gluten.

This damage leads results in an inability of the body to absorb nutrients which are necessary for a healthy body.

It takes the average American over 3 years from recognizing symptoms to be diagnosed with celiac disease.

The best way to fight this disease is through early detection, allowing a patient to adjust their lifestyle habits.

The earlier the diagnosis, the earlier a patient can improve their quality of life by reducing unnecessary pain and suffering.

As a genetic disease, celiac disease could be inherited. Those with family members that have celiac disease are at higher risk.

Someone suffering from autoimmune disease, such as thyroid disease or type 1 diabetes, is at higher risk for celiac disease.

Someone with preexisting genetic disorders, such as Down Syndrome or Turner Syndrome, is at higher risk for celiac disease.

We utilize the same screening biomarkers to track your progression and so you can ensure you're heading towards healing.

We utilized the screening gold standard, the highly sensitive Tissue Transglutaminase (tTG) Antibody, or tTG-IgA biomarker.

For an even more comprehensive view of your results, we also screen for three additional biomarkers: tTG-lgG, DGP-IgG and DGP-IgA.